Jonathan A. Pachter
22Patents
3h-index
38Co-inventors
63Inventor score
Filing activity: Sep 8, 1994 → Nov 25, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7217796B2 | Neutralizing human anti-IGFR antibody | Chemistry; Metallurgy | 60 | Expired |
| US6710037B2 | Method of treating androgen-dependent disorders | Chemistry; Metallurgy | 17 | Expired |
| US10406158B2 | Methods and compositions for treating abnormal cell growth | Human Necessities | 3 | Active |
| US10532056B2 | Therapeutic compositions, combinations, and methods of use | Chemistry; Metallurgy | 3 | Active |
| US9962385B2 | Methods and compositions for treating abnormal cell growth | Human Necessities | 3 | Active |
| US7667021B2 | Neutralizing human anti-IGFR antibody | Chemistry; Metallurgy | 2 | Active |
| US7998688B2 | Inhibition of EMT induction in tumor cells by anti-cancer agents | Physics | 2 | Active |
| US7847068B2 | Neutralizing human anti-IGFR antibody | Chemistry; Metallurgy | 2 | Active |
| US7851181B2 | Neutralizing human anti-IGFR antibody | Chemistry; Metallurgy | 2 | Active |
| US7811562B2 | Biomarkers for pre-selection of patients for anti-IGF1R therapy | Chemistry; Metallurgy | 1 | Expired |
| US8173779B2 | Neutralizing human anti-IGFR antibody | Chemistry; Metallurgy | 1 | Active |
| US6903102B2 | 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | Chemistry; Metallurgy | 1 | Expired |
| US7790474B1 | p53 modulators | Physics | 1 | Active |
| US7432268B2 | 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | Chemistry; Metallurgy | 0 | Active |
| US7485645B2 | 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | Chemistry; Metallurgy | 0 | Active |
| US7138396B2 | 17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | Chemistry; Metallurgy | 0 | Expired |
| US7053091B2 | 17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | Chemistry; Metallurgy | 0 | Expired |
| US5461057A | Hydro-ethano-indeno-pyridines | Chemistry; Metallurgy | 0 | Expired |
| US7271175B2 | 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | Chemistry; Metallurgy | 0 | Expired |
| US8017735B2 | Anti-IGFR1 antibody therapeutic combinations | Chemistry; Metallurgy | 0 | Active |
| US11564927B2 | Therapeutic compositions, combinations, and methods of use | Chemistry; Metallurgy | 0 | Active |
| US6569872B1 | Use of neurokinin receptor antagonists to treat androgen-dependent diseases | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.